Expertise in
24
conditions

Dr. Albert A. Attia

Radiation Oncology
FL - Cancer
4500 San Pablo Rd S, 
Jacksonville, FL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Expertise in
24
conditions
FL - Cancer
4500 San Pablo Rd S, 
Jacksonville, FL 

Overview

Albert Attia is a Radiation Oncologist practicing medicine in Jacksonville, Florida.

Dr. Attia is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Gamma Knife Radiosurgery.

He is actively involved in clinical research, co-authoring 71 peer reviewed articles and participating in 12 clinical trials. Dr. Attia is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in TN

Hospital Affiliations

Mayo Clinic

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

FL - Cancer
4500 San Pablo Rd S, Jacksonville, FL 32224

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Enrollment Status: Recruiting
Publish Date: April 17, 2026
Intervention Type: Other, Device
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: September 11, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drugs: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin acetate, Histrelin acetate, Leuprolide acetate, Nilutamide, Prednisone, Triptorelin
Study Phase: Phase 3
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2026
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Procedure, Radiation
Study Phase: Phase 3
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Other, Drug, Procedure, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 3
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

71 Total Publications

Aligning Medical Education With Modern Cancer Care: The Role of Radiation Oncology.
Aligning Medical Education With Modern Cancer Care: The Role of Radiation Oncology.
Journal: Practical radiation oncology
Published: February 15, 2026
Similar Doctors
Expertise in
63
conditions
Dr. William M. Mendenhall
Radiation Oncology
Expertise in
63
conditions
Dr. William M. Mendenhall
Radiation Oncology
Referral may be required

UF Health Proton Therapy Institute

2015 Jefferson St, 
Jacksonville, FL 
 (14.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Mendenhall is a Radiation Oncologist practicing medicine in Jacksonville, Florida. Dr. Mendenhall is highly rated in 63 conditions, according to our data. His clinical expertise encompasses Sinus Cancer, Laryngeal Cancer, Throat Cancer, Prostatectomy, and Gastrostomy. Dr. Mendenhall is currently accepting new patients.

Expertise in
19
conditions
Dr. Bradford S. Hoppe
Radiation Oncology
Expertise in
19
conditions
Dr. Bradford S. Hoppe
Radiation Oncology
Referral may be required

FL - Cancer

4500 San Pablo Rd S, 
Jacksonville, FL 
 (0.1 miles away)
904-914-7532
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bradford Hoppe is a Radiation Oncologist practicing medicine in Jacksonville, Florida. Dr. Hoppe is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Prostate Cancer, Mediastinal Tumor, Prostatectomy, and Splenectomy. Dr. Hoppe is currently accepting new patients.

Expertise in
44
conditions
Dr. Daniel J. Indelicato
Radiation Oncology
Expertise in
44
conditions
Dr. Daniel J. Indelicato
Radiation Oncology
Referral may be required

UF Health Proton Therapy Institute

2015 Jefferson St, 
Jacksonville, FL 
 (14.5 miles away)
877-686-6009
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Indelicato is a Radiation Oncologist practicing medicine in Jacksonville, Florida. Dr. Indelicato is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Ependymoma, Craniopharyngioma, Rhabdomyosarcoma, and Brain Tumor. Dr. Indelicato is currently accepting new patients.

Frequently Asked Questions about Dr. Albert A. Attia

How do I make an appointment with Dr. Albert A. Attia?

You can book an appointment with Dr. Albert A. Attia by calling their office at 904-914-7532. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Albert A. Attia a top-rated expert for Metastatic Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Albert A. Attia is classified as an Distinguished expert for Metastatic Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Albert A. Attia specialize in?

While Dr. Albert A. Attia is a Radiation Oncology, they have specific expertise in Metastatic Brain Tumor, Brain Tumor, and Posterior Fossa Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Albert A. Attia participate in research or clinical trials?

Yes. Dr. Albert A. Attia has published 71 articles and abstracts on conditions like Metastatic Brain Tumor. You can view a list of Dr. Albert A. Attia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Albert A. Attia accept my insurance?

Dr. Albert A. Attia accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 904-914-7532 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Attia's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile